Oncopharmpod
Tepotinib
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:15:30
- More information
Informações:
Synopsis
In light of teptinib's recent FDA-approval for exon-14 skipping MET altered metastatic NSLCC, we compare tepotinib to its predecessor in this space - capmatinib.
